Clinical Trial Update: A Registry Study of Shuxuening Injection Used in Hospitals in China

View source ↗

Summary

A registry study in China evaluating Shuxuening Injection for cardiovascular and cerebrovascular conditions, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Cerebral Vasospasm
• Coronary Artery Disease
• Stroke

Drugs mentioned

• Shuxuening Injection

Snippet

Sponsor: China Academy of Chinese Medical Sciences | Conditions: Coronary Disease, Intracranial Embolism | Status: UNKNOWN